- Home
- AQST vs SWBI Comparison
AQST vs SWBI Comparison
Compare AQST & SWBI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | AQST | SWBI |
|---|---|---|
| Founded | 2004 | 1852 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Ordnance And Accessories |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 521.0M | 491.2M |
| IPO Year | 2007 | 2000 |
Fundamental Metrics
Financial Performance| Metric | AQST | SWBI |
|---|---|---|
| Price | $4.00 | $14.19 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 5 | 1 |
| Target Price | $9.00 | ★ $14.00 |
| AVG Volume (30 Days) | ★ 1.9M | 547.8K |
| Earning Date | 03-04-2026 | 03-05-2026 |
| Dividend Yield | N/A | ★ 3.66% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.05 |
| Revenue | $67,430,000.00 | ★ $474,661,000.00 |
| Revenue This Year | $10.08 | $2.62 |
| Revenue Next Year | $55.46 | $3.23 |
| P/E Ratio | ★ N/A | $284.30 |
| Revenue Growth | ★ 0.77 | N/A |
| 52 Week Low | $2.20 | $7.73 |
| 52 Week High | $7.55 | $14.51 |
Technical Indicators
Market Signals| Indicator | AQST | SWBI |
|---|---|---|
| Relative Strength Index (RSI) | 45.34 | 71.35 |
| Support Level | $3.69 | $9.51 |
| Resistance Level | $4.46 | $14.51 |
| Average True Range (ATR) | 0.20 | 0.44 |
| MACD | -0.02 | 0.05 |
| Stochastic Oscillator | 1.85 | 87.06 |
Price Performance
Historical ComparisonAbout AQST Aquestive Therapeutics Inc.
Aquestive Therapeutics Inc is a specialty pharmaceutical company engaged in developing and commercializing differentiated products to meet medical needs. Its later-stage product pipeline focuses on the treatment of diseases of the Central Nervous System (CNS), and an earlier-stage pipeline for the treatment of severe allergic reactions, including anaphylaxis. Its commercial product portfolio includes Suboxone, Emylif, Ondif, and Sympazan. The product pipeline includes Libervant Buccal Film, AQST-108. The majority of its revenue comes from the United States.
About SWBI Smith & Wesson Brands Inc.
Smith & Wesson Brands Inc is a U.S.-based leader in firearm manufacturing. It operates under one reportable segment: Firearms, which includes firearms distribution and manufacturing services. The company manufactures handguns, long guns, sporting rifles, shooting gear, and suppressor products. The firm's brand portfolio consists of Smith and Wesson, M&P, Thompson/Center Arms, Performance Center, and Gemtech; which are used for defense, law enforcement, hunting, and sporting purposes. The company operates internationally, with the majority of income generated by the U.S. market from its handgun products.